You are here: Industry Insights > COVID-19

News List

Diabetes drug may lower COVID-19 death risk in women; key immune cells fail to respond to virus expresspharma
June 29, 2020
The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Arch Biopartners to Proceed with Metablok Trial for COVID-19 americanpharmaceuticalreview
June 28, 2020
Arch Biopartners announced the U.S. Food and Drug Administration (FDA) has granted permission to the Company to proceed with a Phase II trial in the U.S. for its lead drug Metablok (LSALT peptide) to prevent acute lung and kidney injury experienced by ...
Over 2,000 clinical trials currently underway for COVID-19 therapies, finds study europeanpharmaceuticalreview
June 28, 2020
New findings have revealed that over 2,000 clinical trials are being conducted to test COVID-19 therapies while 583 companies are involved in treatment and vaccine development.
EMA recommends authorisation for remdesivir to combat COVID-19 europeanpharmaceuticalreview
June 28, 2020
The EMA’s human medicines committee (CHMP) has recommended a conditional marketing authorisation for Veklury (remdesivir) to treat COVID-19.
FDA grants fast track status to NeuroRx’s Covid-19 drug candidate pharmaceutical-technology
June 28, 2020
The US Food and Drug Administration (FDA) has granted fast track designation to RLF-100 (Aviptadil), which is being developed by NeuroRx and Relief Therapeutics to treat acute lung injury / acute respiratory distress syndrome caused by Covid-19.
Avalon GloboCare to develop intranasal and oral Covid-19 vaccine pharmaceutical-technology
June 28, 2020
US-based biotech firm Avalon GloboCare has collaborated with the University of Natural Resources and Life Sciences (BOKU) in Vienna, Austria to develop an S-layer vaccine against Covid-19 for intranasal or oral administration.
India must spend 5 per cent of its GDP on healthcare: CEO of NITI Aayog expresspharma
June 28, 2020
A webinar co-hosted by Harvard T.H. Chan School of Public Health - India Research Center, Piramal Foundation & Project SANCHAR had global panelists highlighting the importance of collaboration to tackle the pandemic and safeguard communities.
Researchers identify six potential drug targets for COVID-19 expresspharma
June 28, 2020
The tumour necrosis factor, granzyme B, heat shock protein 70, interleukin-18, interferon-gamma-inducible protein 10, and elastase were found elevated in COVID-19 ICU patients.
Dexamethasone added to COVID-19 treatment protocol expresspharma
June 28, 2020
The Union Ministry of Health & Family Welfare released an updated clinical management protocol for managing COVID-19 cases which advises the use of Dexamethasone as an alternative choice to Methylprednisolone to manage moderate to severe cases of COVID-19
Research charities warn of funding cuts in coronavirus wake pharmatimes
June 24, 2020
Charities including Cancer Research UK (CR UK) and the British Heart Foundation are warning that research funding will take a substantial hit in the wake of COVID-19 and that this will likely have significant consequences on survival.